[1]王 昱,李耀辉.抗纤汤联合醋酸泼尼松片治疗类风湿关节炎合并肺间质病变气虚血瘀证疗效研究[J].陕西中医,2023,(4):463-466.[doi:DOI:10.3969/j.issn.1000-7369.2023.04.012]
　WANG Yu,LI Yaohui.Effect of Kangxian decoction combined with prednisone acetate tablet in treatment of rheumatoid arthritis complicated with lung interstitial disease of Qixu Xueyu syndrome[J].,2023,(4):463-466.[doi:DOI:10.3969/j.issn.1000-7369.2023.04.012]
点击复制

抗纤汤联合醋酸泼尼松片治疗类风湿关节炎合并肺间质病变气虚血瘀证疗效研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年4期
页码:
463-466
栏目:
临床研究
出版日期:
2023-04-05

文章信息/Info

Title:
Effect of Kangxian decoction combined with prednisone acetate tablet in treatment of rheumatoid arthritis complicated with lung interstitial disease of Qixu Xueyu syndrome
作者:
王 昱1; 2; 李耀辉3
(1.陕西中医药大学,陕西 咸阳 712046; 2.西安市第五医院,陕西 西安 710082; 3.陕西省中医医院,陕西 西安 710003)
Author(s):
WANG Yu; LI Yaohui
(Shaanxi University of Chinese Medicine,Xianyang 712046,China)
关键词:
类风湿关节炎;  肺间质病变;  抗纤汤;  气虚血瘀;  肺功能;  血气分析
Keywords:
Rheumatoid arthritis;  Interstitial pulmonary disease;  Kangxian decoction;  Qi deficiency and blood stasis;  Lung function;  Blood gas analysis
分类号:
R 563
DOI:
DOI:10.3969/j.issn.1000-7369.2023.04.012
文献标志码:
A
摘要:
目的:观察抗纤汤联合醋酸泼尼松片治疗类风湿关节炎合并肺间质病变(RA-ILD)气虚血瘀证的临床疗效。方法:将60例RA-ILD气虚血瘀证患者随机分为治疗组(n=30)和对照组(n=30)。对照组患者采用醋酸泼尼松片口服治疗,治疗组采用抗纤汤联合醋酸泼尼松片治疗,两组疗程均为3个月,观察并记录两组治疗前后的临床症状及体征评分、肺功能、血气分析指标及临床疗效。结果:与治疗前比较,治疗后两组患者干咳、进行性呼吸困难、Velcro啰音评分及肺功能指标、动脉血氧分压(PaO2)均改善(P<0.05); 治疗后治疗组患者干咳、进行性呼吸困难、Velcro啰音评分及肺功能指标、PaO2水平均优于对照组(P<0.05)。治疗组总有效率高于对照组(P<0.05)。结论:抗纤汤联合醋酸泼尼松片治疗RA-ILD可改善患者临床症状和体征,提高肺功能,改善血气指标,安全性好。
Abstract:
Objective:To observe the clinical effect of Kangxian decoction combined with prednisone acetate tablet in the treatment of rheumatoid arthritis combined with lung interstitial disease(RA-ILD)of Qixu Xueyu syndrome.Methods:Sixty patients with RA-ILD Qixu Xueyu syndrome were randomly divided into treatment group(n=30)and control group(n=30).The control group was treated with prednisone acetate tablets,and the treatment group was treated with Kangxian decoction combined with prednisone acetate tablets.The treatment course of both groups was three months.The clinical signs and symptoms scores,lung function,blood gas analysis indexes and clinical effect of both groups before and after treatment were observed and recorded.Results:Compared with before treatment,dry cough,progressive dyspnea,Velcro rales score,lung function index and PaO2 were improved in two groups after treatment(P<0.05).After treatment,dry cough,progressive dyspnea,Velcro rales score,lung function index and PaO2 level in treatment group were better than those in control group(P<0.05).The total effective rate of the treatment group was higher than that of the control group(P<0.05).Conclusion:Kangxian decoction combined with prednisone acetate tablets in the treatment of RA-ILD can improve the clinical symptoms,lung function and blood gas indexes,with good safety.

参考文献/References:

[1] Froidevaux-Janin S,Dudler J,Nicod LP,et al.Interstitial lung disease in rheumatoid arthritis[J].Rev Med Suisse,2011,7(318):2272-2277.
[2] Hyldgaard C,Hilberg O,Pedersen AB,et al.A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease:Comorbidity and mortality[J].Ann Rheum Dis,2017,76(10):1700-1706.
[3] Koduri G,Norton S,Young A,et al.Interstitial lung disease has a poor prognosis in rheumatoid arthritis:Results from an inception cohort[J].Rheumatology,2010,49(8):1483-1489.
[4] 韩雪兰,李 萍,刘 波,等.亚临床型和临床型类风湿关节炎合并间质性肺炎的免疫炎症指标分析[J].中国实验诊断学,2015,19(11):1925-1927.
[5] 中华医学会呼吸病学分会间质性肺疾病学组.特发性肺纤维化诊断和治疗中国专家共识[J].中华结核和呼吸杂志,2016,39(6):427-432.
[6] 中华医学会风湿病学分会.类风湿关节炎诊断及治疗指南[J].中华风湿病学杂志,2010,14(4):265-270.
[7] 李宗英,王俊祥.类风湿关节炎并发肺间质纤维化的相关因素研究[J].中国全科医学,2013,16(1):140-143.
[8] 菅向东,郭广冉,阮艳君,等.类风湿关节炎患者肺间质病变的临床特点及血清细胞因子的变化[J].中华医学杂志,2008,88(27):1884-1887.
[9] Tzouvelekis A,Anevlavis S,Bouros D.Angiogenesis in interstitial lung diseases:A pathogenetic hallmark or a bystander?[J].Respir Res,2006,7(1):82.
[10] 罗 伟,马丽辉,邓黎黎,等.IL-33和IL-17 在类风湿性关节炎合并间质性肺病中的表达及临床意义[J].临床肺科杂志,2019,24(3):38-41.
[11] 杭 程,肖 洋,王高雷,等.米烈汉教授基于宗气为本防治肺纤维化经验浅析[J].陕西中医,2021,42(9):1282-1284.
[12] 葛春蕾,张兴彩,李珂珂.单味中药及其提取物在肺纤维化治疗中的研究进展[J].中医药学报,2020,48(6):67-72.
[13] 粟 倩,吴 萍,夏伯候,等.百合化学成分及药理活性研究进展[J].中国药学杂志,2021,56(11):875-882.
[14] 谢 琦,程雪梅,胡芳弟,等.党参化学成分、药理作用及质量控制研究进展[J].上海中医药杂志,2020,54(8):94-104.
[15] 单晓晓,洪帮振,刘 洁,等.丹参化学成分、药理作用、临床应用的研究进展及质量标志物的预测分析[J].中国中药杂志,2021,46(21):5496-5511.
[16] 胡妮娜,张晓娟.黄芪的化学成分及药理作用研究进展[J].中医药信息,2021,38(1):76-82.
[17] 赵 静,夏晓培.当归的化学成分及药理作用研究现状[J].临床合理用药,2020,13(6):172-174.
[18] 张晓娟,张燕丽,左冬冬.川芎的化学成分和药理作用研究进展[J].中医药信息,2020,37(6):128-133.
[19] 刘 伟,李中燕,田 艳,等.北沙参的化学成分及药理作用研究进展[J].国际药学研究杂志,2013,40(3):291-294.
[20] 邱晓月,景永帅,郑玉光,等.北沙参对免疫系统调节作用研究进展[J].中国药理学与毒理学杂志,2021,35(10):794.
[21] 王春丽,潘春柳,姚李祥,等.鸡血藤的化学成分和药理作用研究进展[J].现代中药研究与实践,2021,35(2):96-102.
[22] 许惠娟,李时悦,廖东江,等.人工冬虫夏草对肺纤维化模型早期肺泡炎阶段的干预作用[J].汕头大学医学院学报,2015,28(2):72-74.
[23] 黄 莺,徐 芳,袁文胜.人工冬虫夏草对特发性肺纤维化上皮-间质转分化中信号通路的影响[J].世界中医药,2021,16(24):3611-3614.
[24] 岳会敏,刘 飞,李范林,等.冬虫夏草菌丝体提取物通过抑制炎性因子及Treg细胞功能缓解肺纤维化[J].中国免疫学杂志,2016,32(10):1472-1476.
[25] 杨 华,米烈汉.抗纤汤治疗肺间质纤维化疗效观察[J].陕西中医,2009,30(4):387-388.
[26] 米烈汉,孙秀珍.抗纤汤治疗特发性肺纤维化13例临床观察[J].光明中医,2004,19(4):59.

相似文献/References:

[1]刘志队,史丽璞.加味桂枝芍药知母汤对活动期寒热错杂型类风湿关节炎患者ESR、CRP和RF调控作用分析*[J].陕西中医,2019,(1):82.
[2]倪丹红,刘 丹,吕琴琴,等.秦息痛片联合传统抗风湿药治疗早期活动性 类风湿关节炎临床研究*[J].陕西中医,2019,(4):484.
[3]刘志队,史丽璞,张铁峰.加味桂枝芍药知母汤治疗寒热错杂型类风湿关节炎临床研究*[J].陕西中医,2019,(7):906.
　LIU Zhidui,SHI Lipu,ZHANG Tiefeng..Clinical analysis of modified Guizhi Fuyao Zhimu decoction in treating cold and hot miscellaneous rheumatoid arthritis[J].,2019,(4):906.
[4]李 锐,叶冰玉△,刘佳钰,等.活血通络汤辨治类风湿关节炎合并肺间质纤维化临床研究*[J].陕西中医,2019,(8):1041.
　LI Rui,YE Bingyu,LIU Jiayu,et al.Brief analysis of Huoxue Tongluo decoction on differentiation and treatment of rheumatoid arthritis with pulmonary interstitial fibrosis[J].,2019,(4):1041.
[5]李 良,孙银娣,李亚峰,等.四妙二藤汤联合双氯芬酸钠对类风湿关节炎患者关节情况、炎症指标和复发率的影响[J].陕西中医,2019,(10):1397.
　LI Liang,SUN Yindi,LI Yafeng,et al.Effect of Simiao Erteng decoction combined with diclofenac sodium on joint condition，inflammation index and recurrence rate in patients with rheumatoid arthritis[J].,2019,(4):1397.
[6]尚 磊,刘 茜△.断藤益母汤甲氨喋呤联合对类风湿性关节炎患者DAS28评分和炎症指标的影响*[J].陕西中医,2019,(10):1400.
　SHANG Lei,LIU Qian..Effect of Duanteng Yimu decoction and methotrexate on DAS28 Score and inflammatory indicators in rheumatoid arthritis patients[J].,2019,(4):1400.
[7]刘 茜,樊亚红△,陈爱林,等.秦息痛药液外敷治疗类风湿关节炎疗效评价*[J].陕西中医,2019,(10):1403.
　LIU Qian,FAN Yahong,CHEN Ailin,et al.Evaluation of the therapeutic effect of external application of Qinxitong liquid onrheumatoid arthritis[J].,2019,(4):1403.
[8]尚磊,李映雪△.补肾通痹汤联合雷公藤多苷治疗老年类风湿关节炎疗效研究*[J].陕西中医,2019,(11):1552.
　SHANG Lei,LI Yingxue..Effect of Bushen Tongbi decoction combined with tripterygium wilfordii polyglycosides in the treatment of eldery rheumatoid arthritis[J].,2019,(4):1552.
[9]杨庆万,安 阳△,项飞燕,等.引火汤对类风湿关节炎患者骨代谢的影响*[J].陕西中医,2020,(1):73.
　YANG Qingwan,AN Yang,XIANG Feiyan,et al.Effect of Yinhuo decoction on bone metabolism in patients with rheumatoid arthritis[J].,2020,(4):73.
[10]田杰祥,王 钢,王 佳,等.中医外治法治疗类风湿关节炎滑膜炎研究进展*[J].陕西中医,2020,(1):131.
　TIAN Jiexiang,WANG Gang,WANG Jia,et al.Research progress of external treatment in the 〖JZ〗treatment of rheumatoid arthritis synovitis[J].,2020,(4):131.

备注/Memo

备注/Memo:
基金项目:陕西省重点研发计划项目(2021SF-259); 国家中医药管理局中医学术流派传承工作室第二轮建设项目[国中医人教函(2019)62号]
更新日期/Last Update: 2023-04-10